Lonza | LONN - Market Capitalization


Lonza reported CHF38.84B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akzo Nobel EUR 10.15B 1.73B Jun/2026
Alcon AG USD 33.76B 3.29B Jun/2026
Almirall EUR 2.76B 472.53M Dec/2025
AstraZeneca USD 289.99B 11.26B Jun/2026
BASF EUR 41.75B 5.02B Jun/2026
Bayer EUR 47.56B 8.87B Jun/2026
Demant DKK 56.79B 10.78B Jun/2026
Fresenius EUR 22.51B 2.45B Jun/2026
Fresenius Medical Care EUR 10.55B 766.96M Jun/2026
Geberit CHF 21.02B 759.86M Dec/2025
Genmab DKK 17.1B 88.06B Jun/2026
Givaudan CHF 29.05B 6.42B Dec/2025
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GN Store Nord DKK 13.17B 2.05B Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Merck EUR 18.98B 27.8B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Philips EUR 23.09B 615.44M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sika AG CHF 26.09B 8.47B Dec/2025
Smith & Nephew USD 12.7B 621.83M Jun/2026
Solvay EUR 2.75B 51.49M Jun/2026
UCB EUR 46.41B 13.94B Dec/2025